Kinesin spindle protein (KSP) inhibitors. Part 7: Design and synthesis of 3,3-disubstituted dihydropyrazolobenzoxazines as potent inhibitors of the mitotic kinesin KSP
R. M. Garbaccio(United States Military Academy), George D. Hartman(Joint BioEnergy Institute), Hans E. Huber(Health Strat (Kenya)), Edward S. Tasber(United States Military Academy), Joseph J. Salata, Thomayant Prueksaritanont(United States Military Academy), Paul J. Coleman(United States Military Academy), Lou Anne Neilson(United States Military Academy), Robert B. Lobell(United States Military Academy), Nancy E. Kohl(United States Military Academy), Keith Rickert(United States Military Academy), Carmen Fernández‐Metzler(United States Military Academy), Kelly Hamilton(United States Military Academy), Eileen S. Walsh(Janssen (Switzerland)), Jeff Bergman(United States Military Academy), Elizabeth Mahan(United States Military Academy), Vicki J. South(United States Military Academy), Ronald E. Diehl(United States Military Academy), Carolyn A. Buser(United States Military Academy), Chunze Li(Nanyang Technological University), Joseph P. Davide(United States Military Academy), Maricel Torrent(United States Military Academy), Youwei Yan(United States Military Academy), Lawrence C. Kuo(United States Military Academy), Donald E. Slaughter(United States Military Academy), Christy M. Olson(United States Military Academy), Weikang Tao(Shanghai Medical Information Center), Mark E. Fraley(United States Military Academy)
Cited by 18
Related Papers
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
|Nature|2017|878
The importance of synthetic chemistry in the pharmaceutical industry
|Science|2019|650
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
|Cancer Immunology Research|2015|440
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors
|Biochemical Journal|2005|396